Amy Tiersten
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 28
- Cancer Treatment and Pharmacology 8
- Cancer survivorship and care 5
- HER2/EGFR in Cancer Research 4
-
- Ovarian cancer diagnosis and treatment 9
- Co-authors
- Dawn L. Hershman (8 shared papers)Daniel Curtis McFarland (5 shared papers)Jimmie C. Holland (4 shared papers)Andrea B. Troxel (7 shared papers)Kelly M. Shaffer (2 shared papers)John P. Crown (2 shared papers)Clifford A. Hudis (2 shared papers)Judith D. Goldberg (6 shared papers)
- Journals
- Gynecologic Oncology (9 papers)Oncology (6 papers)Breast Cancer Research and Treatment (5 papers)Journal of Clinical Oncology (4 papers)Cancer (3 papers)
- Partner nations
- United StatesUnited KingdomTürkiye
In The Last Decade
Amy Tiersten
70 papers receiving 1.7k citations
Amy Tiersten's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 869
- Reproductive Medicine 155
- Cancer Research 221
- Immunology 212
- Obstetrics and Gynecology 70
Countries citing papers authored by Amy Tiersten
This map shows the geographic impact of Amy Tiersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Tiersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Tiersten more than expected).
Fields of papers citing papers by Amy Tiersten
This network shows the impact of papers produced by Amy Tiersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Tiersten. The network helps show where Amy Tiersten may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Tiersten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 197 | |
| 2 | 1995 | 190 | |
| 3 | Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial Hit paper breakdown → | 2023 | 137 |
| 4 | 2003 | 132 | |
| 5 | Reduction of paclitaxel-induced peripheral neuropathy with glutamine. | 2001 | 129 |
| 6 | 1991 | 78 | |
| 7 | 2014 | 74 | |
| 8 | 2018 | 60 | |
| 9 | 2020 | 57 | |
| 10 | 2004 | 55 | |
| 11 | 2018 | 45 | |
| 12 | 2004 | 40 | |
| 13 | 2016 | 30 | |
| 14 | 2009 | 30 | |
| 15 | 2001 | 29 | |
| 16 | Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer. | 1998 | 24 |
| 17 | 2021 | 24 | |
| 18 | 2016 | 23 | |
| 19 | Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer. | 2010 | 21 |
| 20 | 2020 | 21 |
About Amy Tiersten
Amy Tiersten is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Dermatology and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer survivorship and care (5 papers), HER2/EGFR in Cancer Research (4 papers), Immunotherapy and Immune Responses (4 papers), Brain Metastases and Treatment (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). The work is most often cited by research in Oncology (869 citations), Reproductive Medicine (155 citations), Cancer Research (221 citations), Immunology (212 citations) and Obstetrics and Gynecology (70 citations). Amy Tiersten has collaborated with scholars based in United States, United Kingdom and Türkiye. Frequent co-authors include Dawn L. Hershman, Daniel Curtis McFarland, Jimmie C. Holland, Andrea B. Troxel, Kelly M. Shaffer, John P. Crown, Clifford A. Hudis, Judith D. Goldberg, Andrew David Seidman and Sophie Barrett. Their work appears in journals such as Gynecologic Oncology, Oncology, Breast Cancer Research and Treatment, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.